| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
187 |
| Employees |
470 |
| Revenues (TTM) (Millions $) |
82 |
| Net Income (TTM) (Millions $) |
-130 |
| Cash Flow (TTM) (Millions $) |
-79 |
| Capital Exp. (TTM) (Millions $) |
3 |
Business Description
SomaLogic Inc. is a privately held biotechnology company located in Boulder, Colorado, specializing in the development and application of protein detection technology for the advancement of healthcare and diagnostics. The company was founded in 2000 by Larry Gold, a renowned scientist and inventor of the gold standard SELEX technology, which is used for the identification of specific protein binding molecules.
The companyes proprietary SOMAscan platform is based on a modified version of DNA aptamers, which are short single-stranded DNA molecules that bind specifically to target proteins with high affinity and selectivity. The SOMAscan assay measures the levels of over 7,000 different proteins in a single serum or plasma sample, providing a comprehensive and highly sensitive esnapshote of an individuales health status.
SomaLogic has developed strategic partnerships with multiple organizations and institutions to apply the SOMAscan technology in different settings. The company has collaborated with the National Institutes of Health (NIH) to study biomarker discovery in a wide range of diseases, including Alzheimeres disease, cancer, heart disease, infectious diseases, and metabolic disorders.
SomaLogic has also partnered with several pharmaceutical companies to assist in drug discovery and development, including Novartis, Bristol Myers Squibb, and Debiopharm Group. Through these partnerships, the SOMAscan technology has been used to identify potential targets for drug development, validate drug candidates, and assess drug efficacy and safety.
In addition to its research and development efforts, SomaLogic offers commercial services for healthcare and pharmaceutical companies, including biomarker discovery, drug development support, and clinical testing, among others.
Overall, SomaLogic is a leader in the field of protein detection and personalized medicine, providing innovative solutions for research and clinical diagnostics. As the company continues to expand and develop new applications for its platform technology, it has the potential to revolutionize the way we diagnose and treat disease.
Company Address: 2945 Wilderness Place Boulder 80301 CO
Company Phone Number: 625-9000 Stock Exchange / Ticker: NASDAQ SLGC
|
%
28.3%